GENI — Genincode Income Statement
0.000.00%
Last trade - 00:00
- £15.48m
- £10.60m
- £1.43m
2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | Interim Report | ARS | ARS |
Standards: | — | IFRS | IFRS |
Status: | Final | Final | Final |
Revenue | |||
Total Revenue | 0.961 | 1.15 | 1.43 |
Cost of Revenue | |||
Gross Profit | 0.523 | 0.593 | 0.632 |
Selling / General / Administrative Expenses | |||
Depreciation and Amortization | |||
Unusual Expense / Income | |||
Total Operating Expenses | 2.01 | 5.3 | 7.33 |
Operating Profit | -1.05 | -4.15 | -5.9 |
Total Net Non Operating Interest Income / Expense | |||
Other Net Non Operating Costs | |||
Net Income Before Taxes | -1.05 | -4.14 | -5.75 |
Provision for Income Taxes | |||
Net Income After Taxes | -1.17 | -4.14 | -5.56 |
Net Income Before Extraordinary Items | |||
Net Income | -1.17 | -4.14 | -5.56 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | -1.17 | -4.14 | -5.56 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | -0.012 | -0.039 | -0.058 |
Dividends per Share |